我院2013－2015年特殊使用级抗菌药物应用分析

摘要

OBJECTIVE:To provide reference for rational utilization of antibiotics for special use. METHODS:Medical orders of antibiotics for special use in clinical departments of our hospital during 2013 to 2015 were selected from hospital information sys-tem. The consumption sum and its ratio,DDDs,DDC,DUI and the utilization of antibiotics for special use in clinical departments were calculated and analyzed. RESULTS:The consumption sum and its ratio of antibiotics for special use in our hospital during 2013 to 2015 both reduced year by year,decreasing from 21 872 200 yuan(48.00%)to 20 877 700 yuan(39.41%). The consump-tion sum ratio of carbapenems,cephalosporins and anti-deep fungal drugs showed descending tendency. The consumption sum ratio of anti-MRSA antibiotics changed slightly. DDDs of Meropenem for injection always took up the first place in recent 3 years,but the values were decreasing. DUI of Imipenem and cilastain sodium for injection was far less than 1,while those of Panipenem and betamipron for injection,Cefepime sodium for injection and Caspofungin acetate for injection(70 mg/injection)were far more than 1. The types of drug with DUI ranged 0.9-1.1 increased year by year,increasing from 3 types in 2013 (18.75%) to 10 types in 2015 (62.50%). Within 3 years, the utilization ratio of antibiotics for special use always took up the first place in ICU (86.64%-87.78%). CONCLUSIONS:The consumption sum and its ratio of antibiotics for special use in our hospital during 2013 to 2015 decreased year by year,and the utilization of antibiotics for special use become increasingly rational. But,there still are some problems,such as inadequate dose of Imipenem and cilastain sodium for injection,overdose of Panipenem and betamipron for injection,Cefepime sodium for injection and Caspofungin acetate for injection(70 mg/injection).%目的：为特殊使用级抗菌药物临床合理使用提供参考。方法：从医院信息系统提取我院各科室2013－2015年使用特殊使用级抗菌药物的医嘱信息，计算和分析特殊使用级抗菌药物销售金额及占比、使用频度（DDDs）、日均费用（DDC）、药物利用指数（DUI）以及各科室使用情况。结果：我院2013－2015年特殊使用级抗菌药物销售金额及其占抗菌药物总销售金额的比例（金额比）呈逐年下降趋势，由2187.22万元（48.00％）下降至2087.77万元（39.41％）。碳青霉烯类、头孢菌素类和深部抗真菌药的金额比呈下降趋势；抗耐甲氧西林金黄色葡萄球菌（MRSA）类抗菌药物的金额比变化不大。注射用美罗培南DDDs连续3年排名第1，但呈递减趋势。注射用亚胺培南西司他丁钠的DUI值远＜1，而注射用帕尼培南倍他米隆、注射用头孢吡肟钠和注射用醋酸卡泊芬净（70 mg/支）的DUI值远＞1；DUI值为0.9～1.1的药品逐年增加，由2013年的3种（18.75％）增加至2015年的10种（62.50％）。3年中加强医疗科特殊使用级抗菌药物使用率始终占第1位（86.64％～87.78％）。结论：我院2013－2015年特殊使用级抗菌药物销售金额及占比逐年降低，使用日趋合理；但仍存在注射用亚胺培南西司他丁钠用药剂量不足，注射用帕尼培南倍他米隆、注射用头孢吡肟钠和注射用醋酸卡泊芬净（70 mg/支）用药剂量过高等问题。